InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: skezan post# 45216

Friday, 08/23/2019 11:28:50 PM

Friday, August 23, 2019 11:28:50 PM

Post# of 232961
More trouble for Cytodyn, GlaxoSmithKline already advanced in phase 3 with one treatment for HIV every 2 months, which is beyond what Pro-140 achieves.

https://endpts.com/eight-weeks-between-each-hiv-treatment-gsk-notches-phiii-win-as-it-chases-ok-for-long-acting-regimen/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News